Incremental Costs in Giant Cell Arteritis

ConclusionThis study provide an accurate assessment of GCA costs during a five year period and gives useful information for future cost‐effectiveness studies based on new expensive biotherapies.This article is protected by copyright. All rights reserved.

Source: Arthritis Care and Research - October 3, 2017 Category: Rheumatology Authors: Michael Mouni é, Nadège Costa, Laurent Sailler, Maryse Lapeyre‐Mestre, Robert Bourrel, Nicolas Savy, Laurent Molinier, Grégory Pugnet Tags: Original Article Source Type: research